Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-MALT marginal zone lymphoma.
Thieblemont C, Davi F, Noguera ME, Brière J. Thieblemont C, et al. Curr Opin Hematol. 2011 Jul;18(4):273-9. doi: 10.1097/MOH.0b013e3283477815. Curr Opin Hematol. 2011. PMID: 21577105 Review.
Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C, Davi F, Noguera ME, Brière J, Bertoni F, Zucca E, Traverse-Glehen A, Felman P, Berger F, Salles G, Coiffier B. Thieblemont C, et al. Oncology (Williston Park). 2012 Feb;26(2):194-202. Oncology (Williston Park). 2012. PMID: 22489356 Free article.
Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients.
Monjanel H, Deville L, Ram-Wolff C, Venon MD, Franchi P, Benet C, de Kerviler E, Malphettes M, Thieblemont C, Brice P. Monjanel H, et al. Among authors: thieblemont c. Br J Haematol. 2014 Jul;166(2):306-8. doi: 10.1111/bjh.12849. Epub 2014 Mar 27. Br J Haematol. 2014. PMID: 24673542 Free article. Clinical Trial. No abstract available.
Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment.
Amorim S, Fleury I, Mounier N, Harel S, Brice P, Thieblemont C. Amorim S, et al. Among authors: thieblemont c. Leuk Lymphoma. 2016 Oct;57(10):2425-8. doi: 10.3109/10428194.2015.1135437. Epub 2016 Jan 11. Leuk Lymphoma. 2016. PMID: 26750643 No abstract available.
Optimizing therapy for nodal marginal zone lymphoma.
Thieblemont C, Molina T, Davi F. Thieblemont C, et al. Blood. 2016 Apr 28;127(17):2064-71. doi: 10.1182/blood-2015-12-624296. Epub 2016 Mar 17. Blood. 2016. PMID: 26989202 Free article. Review.
Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
Bigenwald C, Harel S, Chevignon F, Roos-Weil D, Bernard OA, Amorim S, Brice P, Adès L, Nloga AM, Sébert M, Braun T, Eclache V, Thieblemont C, Fenaux P. Bigenwald C, et al. Among authors: thieblemont c. Br J Haematol. 2018 Jan;180(2):304-308. doi: 10.1111/bjh.14323. Epub 2016 Sep 23. Br J Haematol. 2018. PMID: 27662562 Free article. No abstract available.
406 results